Services

Taj Pharma provides a broad range of pharmaceutical development, regulatory, manufacturing, supply, and market-access services designed to support pharmaceutical companies, distributors, hospitals, NGOs, government procurement agencies, and international partners.

Our service portfolio covers the complete lifecycle of a pharmaceutical product—from regulatory strategy and dossier preparation through technology transfer, process validation, stability studies, commercial manufacturing, hospital supply, and institutional tenders.

The following knowledge base provides a structured overview of the major services offered through the Taj Pharma platform.


1. Regulatory Affairs

Overview

Regulatory Affairs is a critical component of pharmaceutical product development, registration, commercialization, and lifecycle management. Taj Pharma supports regulatory activities by coordinating technical, quality, manufacturing, and product information required for pharmaceutical registration in target markets.

Our regulatory approach is designed to help partners understand country-specific requirements, organize registration documentation, prepare submission-ready technical information, and support communication throughout the regulatory process.

Key Regulatory Affairs Services

Regulatory Strategy

We assess the intended market and product requirements to establish an appropriate regulatory pathway. Regulatory planning may consider:

  • Product type
  • Dosage form
  • Strength
  • Therapeutic category
  • Target country
  • Registration pathway
  • Required technical documentation
  • Manufacturing-site requirements
  • GMP requirements
  • Stability requirements
  • Bioequivalence requirements where applicable
  • Product-specific regulatory requirements

Product Registration Support

We support preparation and coordination of documentation required for registration of pharmaceutical products in international markets.

Depending on the country and product, regulatory documentation may include:

  • Administrative information
  • Product information
  • Manufacturing information
  • Pharmaceutical development information
  • Quality documentation
  • Analytical methods
  • Specifications
  • Validation documentation
  • Stability data
  • Packaging information
  • Manufacturing-site information
  • GMP documentation
  • Certificates and declarations
  • Clinical or bioequivalence documentation where applicable

Regulatory Documentation Management

Effective regulatory affairs requires controlled management of technical documents and supporting evidence.

Our regulatory documentation activities may include:

  • Document collection
  • Document review
  • Document indexing
  • Technical document coordination
  • Submission-document organization
  • Deficiency-response coordination
  • Regulatory correspondence management
  • Product lifecycle documentation

Regulatory Markets

Taj Pharma’s international business activities have included pharmaceutical markets across regions such as:

  • Africa
  • Southeast Asia
  • CIS countries
  • Middle East
  • Central America
  • Latin America

Country-specific regulatory requirements should always be evaluated before submission because registration procedures, document requirements, legalization requirements, GMP expectations, and timelines vary between jurisdictions.


2. Pharmaceutical Dossier Services

Overview

A pharmaceutical dossier is the organized technical and regulatory package submitted to a health authority to support the registration of a pharmaceutical product.

Taj Pharma supports dossier preparation and compilation using structured pharmaceutical information covering the product’s quality, manufacturing, analytical, stability, and regulatory characteristics.

CTD and eCTD Dossiers

Depending on the target market and regulatory authority, pharmaceutical information may be organized according to internationally recognized dossier structures such as the Common Technical Document (CTD) or electronic CTD formats.

A typical CTD structure contains:

Module 1 – Administrative and Regional Information

This module contains country-specific administrative and regulatory information.

Typical documents may include:

  • Application forms
  • Authorization documents
  • Manufacturing-site information
  • Product information
  • Labeling
  • Packaging information
  • Certificates
  • Regional declarations

Module 2 – Common Technical Document Summaries

Module 2 provides summaries of information contained in the technical modules.

It may include:

  • Quality Overall Summary
  • Nonclinical Overview
  • Clinical Overview
  • Quality summaries

Module 3 – Quality

Module 3 is central to pharmaceutical product registration and covers the quality and manufacturing information.

It may include information concerning:

  • Active pharmaceutical ingredient
  • Excipients
  • Finished product
  • Manufacturing process
  • Process controls
  • Specifications
  • Analytical procedures
  • Analytical validation
  • Batch analysis
  • Container-closure system
  • Stability studies

Module 4 – Nonclinical Information

Where applicable, this module contains nonclinical documentation supporting the product.

Module 5 – Clinical Information

Depending on the product and regulatory pathway, Module 5 may contain:

  • Clinical study reports
  • Bioavailability studies
  • Bioequivalence studies
  • Literature references
  • Other clinical documentation

The exact dossier structure and supporting documentation depend on the product and regulatory jurisdiction.


3. Drug Master Files (DMFs)

Overview

A Drug Master File (DMF) contains confidential technical information relating to the manufacture, processing, packaging, and quality control of an active pharmaceutical ingredient, excipient, or other relevant pharmaceutical material.

DMFs can allow confidential technical information to be submitted to a regulatory authority while permitting an applicant or finished-product manufacturer to reference the information through an appropriate authorization mechanism.

DMF Support

Taj Pharma’s regulatory and technical activities can support the organization and management of information required for DMF-related submissions.

Depending on the product and regulatory system, relevant information can include:

  • Manufacturer information
  • Manufacturing process
  • Process controls
  • Raw materials
  • Starting materials
  • Specifications
  • Analytical methods
  • Analytical validation
  • Impurity profile
  • Packaging
  • Stability information
  • Manufacturing-site information
  • Quality-control information

DMF Lifecycle Management

DMF activities do not necessarily end with the initial submission.

Lifecycle activities may include:

  • Initial preparation
  • Submission coordination
  • Regulatory correspondence
  • Deficiency responses
  • Amendments
  • Updates
  • Technical changes
  • Annual or periodic maintenance where required
  • Change-control documentation

DMF requirements differ by regulatory authority, so the appropriate DMF format and submission procedure must be established for the intended market.


4. Process Validation

Overview

Process validation provides documented evidence that a pharmaceutical manufacturing process is capable of consistently producing a product meeting predetermined quality requirements.

Taj Pharma’s manufacturing and technical services can support validation activities associated with pharmaceutical production and technology implementation.

Process Validation Activities

A process-validation program may involve:

  1. Process understanding
  2. Identification of critical process parameters
  3. Identification of critical quality attributes
  4. Risk assessment
  5. Manufacturing-process development
  6. Validation protocol preparation
  7. Validation batch execution
  8. Sampling
  9. Testing
  10. Data evaluation
  11. Validation-report preparation
  12. Continued process verification where applicable

Validation Documentation

Typical documentation may include:

  • Validation master plan
  • Process-validation protocol
  • Batch manufacturing records
  • Sampling plans
  • Analytical results
  • Process parameters
  • Acceptance criteria
  • Deviations
  • Investigation reports
  • Corrective and preventive actions
  • Final validation report

Importance of Process Validation

A robust validation approach helps demonstrate that manufacturing processes operate consistently and that critical process parameters remain within established limits.

For pharmaceutical manufacturers, process validation is particularly important when establishing:

  • New products
  • New manufacturing processes
  • New manufacturing equipment
  • Technology-transfer processes
  • Significant process changes
  • Commercial-scale production

5. Stability Studies

Overview

Stability studies evaluate how the quality of a pharmaceutical product changes over time under specified environmental conditions.

Stability data are important for establishing or supporting:

  • Shelf life
  • Retest period
  • Storage conditions
  • Packaging suitability
  • Product quality over time

Stability Study Programs

A pharmaceutical stability program may include different study conditions depending on the applicable regulatory requirements and intended market.

The study design may consider:

  • Long-term stability
  • Accelerated stability
  • Intermediate conditions where applicable
  • Photostability where required
  • In-use stability where applicable
  • Reconstitution stability for appropriate products
  • Stability after opening where applicable

Stability Parameters

Testing may include appropriate quality attributes such as:

  • Appearance
  • Identification
  • Assay
  • Degradation products
  • Dissolution
  • Water content
  • pH
  • Microbiological quality
  • Sterility
  • Particulate matter
  • Other product-specific parameters

The precise stability protocol depends on the dosage form, formulation, packaging system, active ingredient, and regulatory requirements.

Stability for Registration

Stability data may form an important component of the pharmaceutical registration dossier.

The resulting data can be used to support:

  • Proposed shelf life
  • Storage conditions
  • Packaging configuration
  • Product quality claims
  • Regulatory submissions

6. Technology Transfer

Overview

Technology transfer is the controlled transfer of product and process knowledge from one manufacturing or development environment to another.

Taj Pharma supports technology-transfer activities intended to establish reproducible manufacturing processes at the receiving facility.

Technology Transfer Scope

A technology-transfer program can include:

  • Product formulation information
  • Manufacturing process
  • Process parameters
  • Raw-material specifications
  • Packaging specifications
  • Analytical methods
  • Analytical procedures
  • Equipment requirements
  • Process controls
  • Cleaning requirements
  • In-process testing
  • Finished-product testing
  • Stability requirements

Technology Transfer from Development to Manufacturing

A common technology-transfer pathway involves transferring a product from a development environment to a commercial manufacturing facility.

The process can include:

Development → Technical Assessment → Gap Analysis → Transfer Protocol → Engineering/Trial Batches → Validation → Commercial Manufacturing

Technology Transfer Documentation

Typical documentation may include:

  • Technology-transfer plan
  • Product development report
  • Master formula
  • Manufacturing process description
  • Analytical method documentation
  • Specifications
  • Validation documentation
  • Equipment requirements
  • Risk assessments
  • Transfer protocols
  • Transfer reports

Effective technology transfer helps ensure that the receiving site understands the product, process, controls, analytical requirements, and critical manufacturing parameters.


7. Contract Manufacturing

Overview

Contract manufacturing allows pharmaceutical companies, marketing authorization holders, distributors, and other organizations to outsource manufacturing activities to an appropriately qualified pharmaceutical manufacturing partner.

Taj Pharma provides contract manufacturing opportunities across selected pharmaceutical dosage forms and product categories.

Contract Manufacturing Capabilities

Depending on the product and facility, manufacturing capabilities can include:

  • Tablets
  • Capsules
  • Dry powders
  • Granules
  • Effervescent tablets
  • Oral jelly
  • Oral sachets
  • Creams
  • Ointments
  • Liquid injections
  • Vial injections
  • Ampoule injections
  • Dry injections
  • Lyophilized injections
  • Small-volume parenterals
  • Large-volume parenterals
  • Prefilled syringes
  • Oncology formulations
  • Beta-lactam products
  • Nutraceuticals
  • Food supplements

Contract Manufacturing Process

A typical contract-manufacturing engagement may follow:

1. Product Requirement

The customer provides product details, target market, required quantity, dosage form, strength, packaging requirements, and regulatory expectations.

2. Technical Evaluation

The product is assessed against available manufacturing capabilities, equipment, technical requirements, and regulatory considerations.

3. Commercial Evaluation

Commercial terms, minimum order quantities, packaging, timelines, and supply requirements are evaluated.

4. Documentation

Required technical and quality documentation is exchanged and reviewed.

5. Manufacturing

Following completion of applicable technical and quality arrangements, manufacturing is scheduled.

6. Quality Control and Release

Manufactured batches undergo applicable testing and quality review before release according to the agreed quality system and regulatory requirements.


8. Hospital Supply

Overview

Taj Pharma supports pharmaceutical supply requirements for hospitals, healthcare institutions, distributors, and institutional procurement channels.

Hospital supply requires reliable product availability, appropriate documentation, compliant packaging, quality assurance, and efficient logistics.

Hospital Supply Categories

Depending on market and product availability, hospital-oriented supply may include:

  • Injectable medicines
  • IV solutions
  • Antibiotics
  • Critical-care medicines
  • General pharmaceutical products
  • Oncology medicines
  • Tablets
  • Capsules
  • Other hospital-use formulations

Hospital Procurement Support

Our institutional supply approach can include coordination of:

  • Product specifications
  • Registration status
  • Manufacturing documentation
  • Product availability
  • Commercial quotations
  • Packaging requirements
  • Delivery schedules
  • Batch documentation
  • Certificates of Analysis
  • Other quality documents required by the purchaser

Hospital requirements differ substantially between institutions and countries. Product registration and procurement eligibility should therefore be confirmed for each market.


9. NGO & Tender Supply

Overview

NGO and institutional tenders represent an important pharmaceutical procurement channel for medicines required by humanitarian organizations, government programs, healthcare institutions, international procurement agencies, and public-sector organizations.

Taj Pharma supports tender-oriented pharmaceutical supply by coordinating product information, commercial proposals, documentation, manufacturing capabilities, and supply requirements.

Tender Support Services

Tender-related support may include:

  • Tender opportunity evaluation
  • Product matching
  • Technical specification review
  • Product documentation
  • Regulatory documentation
  • Manufacturing information
  • Certificates
  • Commercial quotation
  • Packaging specifications
  • Supply schedules
  • Production planning
  • Logistics coordination
  • Tender clarification support

Tender Documentation

Depending on the tender authority, documentation may include:

  • Product registration certificates
  • GMP documentation
  • Manufacturing authorization
  • Product specifications
  • Certificate of Analysis
  • Stability information
  • Product dossiers
  • Packaging information
  • Shelf-life information
  • Samples
  • Manufacturer declarations
  • Quality certificates
  • Country-specific documents

The precise documentation package depends on the tender’s published requirements.

NGO Pharmaceutical Supply

NGO procurement can involve urgent or large-scale requirements for essential medicines. Our manufacturing and supply capabilities can support appropriate pharmaceutical products according to market authorization, customer specifications, production capacity, and contractual requirements.

Government and Institutional Tenders

Public-sector tenders may require detailed compliance with technical, commercial, regulatory, packaging, delivery, and documentation conditions.

Our tender-support process can therefore coordinate information across:

Regulatory → Quality → Manufacturing → Commercial → Supply Chain → Documentation

This integrated approach helps ensure that tender submissions are evaluated against the specific requirements established by the purchasing authority.


10. Integrated Taj Pharma Service Model

Taj Pharma’s services can support pharmaceutical partners at multiple stages of the product lifecycle.

The integrated model can be represented as:

Regulatory Strategy

Dossier Preparation

DMF / Technical Documentation

Technology Transfer

Process Validation

Stability Studies

Commercial Manufacturing

Regulatory Maintenance

Hospital / Distributor / NGO / Tender Supply

This integrated structure enables pharmaceutical partners to coordinate technical, regulatory, manufacturing, and commercial activities through a connected service framework.


11. Why Choose Taj Pharma Services?

Our service model is built around the combination of pharmaceutical manufacturing capabilities, regulatory coordination, technical documentation, specialized dosage-form production, and international supply experience.

Key service strengths include:

  • Multi-dosage-form manufacturing capabilities
  • Specialized injectable manufacturing
  • Oncology manufacturing capabilities
  • Beta-lactam manufacturing capabilities
  • Large-volume parenteral capabilities
  • Oral solid dosage manufacturing
  • Nutraceutical manufacturing
  • Regulatory and dossier support
  • Technology-transfer support
  • Process-validation support
  • Stability-study coordination
  • Contract manufacturing
  • Institutional supply
  • NGO and tender support
  • International pharmaceutical market experience

12. Frequently Asked Questions

What pharmaceutical services does Taj Pharma provide?

Taj Pharma’s service portfolio includes Regulatory Affairs, Dossier preparation, Drug Master File support, Process Validation, Stability Studies, Technology Transfer, Contract Manufacturing, Hospital Supply, and NGO & Tender Supply.

Does Taj Pharma provide contract manufacturing?

Yes. Contract manufacturing can be considered across suitable dosage forms and product categories based on manufacturing capability, technical feasibility, regulatory requirements, capacity, and commercial terms.

Can Taj Pharma support pharmaceutical dossiers?

Yes. Dossier activities can include organization and coordination of administrative, quality, manufacturing, analytical, stability, and other technical documentation required for the applicable regulatory submission.

What is included in technology transfer?

Technology transfer can cover product knowledge, manufacturing processes, critical parameters, specifications, analytical methods, equipment requirements, process controls, validation requirements, and associated technical documentation.

Does Taj Pharma support hospital supplies?

Taj Pharma can support institutional and hospital-oriented pharmaceutical supply requirements subject to product availability, registration status, market requirements, manufacturing capacity, and agreed commercial conditions.

Does Taj Pharma participate in NGO and government tenders?

Taj Pharma can support suitable NGO, institutional, and tender opportunities by coordinating technical documentation, product information, commercial quotations, manufacturing requirements, and supply planning according to the tender conditions.

Can Taj Pharma support international pharmaceutical registration?

Regulatory and dossier support can be coordinated for international markets, with the exact registration pathway and documentation determined by the target country’s regulatory authority and the specific pharmaceutical product.


13. Service Enquiry

Organizations interested in Taj Pharma services can provide the following information for an initial technical and commercial assessment:

  • Product name
  • Active ingredient
  • Strength
  • Dosage form
  • Required quantity
  • Target country
  • Registration status
  • Required regulatory pathway
  • Packaging requirements
  • Target delivery date
  • Tender reference, if applicable
  • Required certificates or documentation
  • Manufacturing or technology-transfer requirements

Following receipt of the product and market requirements, the appropriate Regulatory, Technical, Quality, Manufacturing, and Commercial teams can evaluate the opportunity and determine the applicable service pathway.


Taj Pharma Services – Complete Pharmaceutical Support

Taj Pharma’s service portfolio brings together regulatory affairs, pharmaceutical dossiers, DMF documentation, process validation, stability studies, technology transfer, contract manufacturing, hospital supply, and NGO/tender support.

By combining technical pharmaceutical capabilities with regulatory and commercial coordination, the service platform is designed to support pharmaceutical companies and institutional partners from product development and registration through manufacturing and supply.